title: Effect of intraluminal distension or ischemic strangulation obstruction of the equine jejunum on jejunal motilin receptors and binding of erythromycin lactobionate.
abstract: OBJECTIVE
  To determine whether inflammation of the jejunum of horses decreases the number of motilin receptors and amounts of motilin receptor mRNA and alters erythromycin lactobionate binding affinity to the motilin receptor in jejunal tissues.
  
  
  METHODS
  Jejunal segments in 6 adult horses.
  
  
  METHODS
  Each horse was anesthetized, and a ventral median celiotomy was performed; 2 segments of jejunum underwent a sham operation, 2 segments underwent ischemic strangulation obstruction (ISO), and 2 segments underwent intraluminal distension (ILD). Treatments were maintained for 120 minutes. From each segment, full-thickness biopsy samples were collected and smooth-muscle homogenates were prepared. Affinity and distribution of motilin binding to these preparations were determined by use of iodine 125 (125I)-labeled synthetic porcine motilin. Via displacement experiments, competition between 125I-labeled motilin and erythromycin lactobionate for binding to motilin receptors in the different segments was investigated. A quantitative real-time PCR technique was used to assess motilin receptor mRNA content in the muscle preparations.
  
  
  RESULTS
  Compared with the ISO or ILD segments, the number of motilin receptors was significantly higher in the sham-operated segments; ILD segments contained the lowest number of motilin receptors. The expression of motilin receptor mRNA was significantly decreased in ILD segments but not in ISO segments. Erythromycin lactobionate displacement of 125I-labeled motilin from motilin receptors did not differ significantly among the jejunal segments.
  
  
  CONCLUSIONS
  Results suggest that downregulation and decreased production of motilin receptors in inflamed jejunal tissue contribute to the altered prokinetic response to erythromycin in horses with gastrointestinal disease.
authors.affiliation: Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, Canada.
authors.forename: Judith B
authors.initials: JB
authors.lastname: Koenig
authors.forename: Sukhminder
authors.initials: S
authors.lastname: Sawhney
authors.forename: Nathalie
authors.initials: N
authors.lastname: Cote
authors.forename: Jonathan
authors.initials: J
authors.lastname: LaMarre
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000378:metabolism; D004917:Erythromycin / Q000031:analogs & derivatives* / Q000378:metabolism; D006734:Horse Diseases / Q000503:physiopathology*; D006736:Horses; D007249:Inflammation / Q000503:physiopathology; D007415:Intestinal Obstruction / Q000662:veterinary*; D007583:Jejunum / Q000502:physiology*; D011485:Protein Binding; D012333:RNA, Messenger; D011964:Receptors, Gastrointestinal Hormone / Q000378:metabolism*; D018013:Receptors, Neuropeptide / Q000378:metabolism*
chemical_list: D000900:Anti-Bacterial Agents; D012333:RNA, Messenger; D011964:Receptors, Gastrointestinal Hormone; D018013:Receptors, Neuropeptide; C050802:motilin receptor; C010948:erythromycin lactobionate; D004917:Erythromycin